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Introduction. Influenza epidemics are one of the main causes of 
morbidity and mortality worldwide. Influenza vaccination is con-
sidered the most important public health intervention to prevent 
seasonal influenza infection. European health authority policies 
focus on patient protection by vaccinating both these subjects and 
their care-givers, including health-care workers (HCWs). The aim 
of this survey is to investigate knowledge about influenza vacci-
nation and intention to get vaccinated among Italian HCWs who 
take care patients with respiratory disease.
Methods. An anonymous web-based survey was addressed to 
members of the Italian Respiratory Society (IRS).
Results. Among the 1,776 IRS members who have been invited 
to the survey, 144 (8.1%) completed the survey (97 men; median 
age 59 years; 85.4% Respiratory Disease). The vast majority 
recommended vaccination to all their patients (81%). More than 
two thirds of respondents considered influenza vaccination safe 
for immunocompromised patients. More than 50% of respond-
ents underwent seasonal influenza vaccination in 2015 and 68% 
declared the intention to undergo vaccination in 2016 epidemic 
season. Reasons for having vaccination mainly referred to ‘pro-
tect oneself from influenza’ (63%), ‘protect patients’ (31%) or 
household members’ (6%). The main reasons for vaccination 
refusal were ‘lack of time’ (45%), ‘concerns about side effects’ 
(22%), ‘do not get influenza easily and/or not afraid of influenza 
infection’ (22%) and ‘disagreement with indication of vaccination 
for HCWs’ (9%). 
Conclusions. The promotion of better knowledge and attitude 
towards influenza vaccination among Italian specialists remains 
an unmet goal and should be addressed by appropriate multifac-
eted interventions.
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Introduction
Influenza is one of the main causes of morbidity and 
mortality worldwide, especially among elderly and pa-
tients with chronic medical conditions [1]. Influenza 
epidemics represent a public health problem in Europe 
causing an increase in lost productivity and health-re-
lated costs due to complications especially among high 
risk patients [2, 3]. Influenza vaccination is considered 
the most important public health intervention to prevent 
seasonal influenza transmission and infection [2]. Eu-
ropean guidelines and health authority policies for in-
fluenza focus on protecting high risk patients vaccinat-
ing both these subjects and their care-givers, including 
health-care workers (HCWs) [4]. 
A recent meta-analysis confirmed that influenza vacci-
nation among HCWs is effective in preventing mortal-
ity and influenza spread [5]. Despite several efforts have 
been made over the past decade to promote influenza 
vaccination programs, vaccination levels among HCWs 
are still unsatisfactory worldwide [6]. For this reason, 
we aimed at investigating knowledge about seasonal in-
fluenza vaccination among Italian physicians who take 
care patients with respiratory disease, as well as inten-
tion to get vaccinated themselves and prevalence of vac-
cination in HCWs population.
Methods
An anonymous web-based survey was designed by a 
task-force of the Italian Respiratory Society (IRS) in-
cluding respiratory diseases and infectious diseases 
specialists. The questionnaire was available through 
web link pages and included multiple-choice questions 
(Tab. I). Respondents were allowed to give their reasons 
for having or not seasonal influenza vaccination as free 
additional text. The results are reported as mean ± IQR 
or proportion (%). Fisher’s exact test was employed to 
compare categorical variables and continuous variables 
between groups, respectively. IBM SPSS software was 
used to statistical analyses.
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Tab. I. Web-based survey questionnaire and results.
1. Demographics 
Male 97 (67.4%)
Median age 59 (47 – 66)
Respiratory disease 123 (85.4%)
Internal medicine 12 (8.3%)
Infectious disease 9 (6.3%)
Employed at academic institutions 30 (20.8%)
2. Working place and Italian region where the activity takes place
Northern Italy 53 (36.8%)
Central Italy 31 (21.5%)
Southern Italy 60 (41.7%)
3. What is the percentage of time that you spend in contact with patients?
More than 50% 117 (81.2%)
Less than 50% 27 (18.8%)
4. Did you undergo influenza vaccination last year (2015-2016)?
Yes 79 (54.9%)
No 65 (45.1%)
5. Are you planning to have vaccination or have you already did it this year (2016-2017)?
Yes 99 (68.7%)
No 45 (31.3%)
6. Do you incur the risk to get influenza by vaccination?
Yes 29 (20.1%)
No 115 (79.9%)
7. Is it safe for immunosuppressed patients to undergo vaccination? 
Yes 120 (83.3%)
No 24 (16.7%)
8. Can influenza vaccination be dispensed in association with anti-pneumococcal? 
Yes 142 (98.6%)
9. What kinds of influenza vaccinations are available in your countries?
Trivalent injectable influenza vaccine 59 (40.1%)
Quadrivalent injectable influenza vaccine 70 (48.6%)
Others 15 (11.3%)
10. Is influenza vaccination mandatory at your jobsite? 
Yes 7 (4.9%)
No 137 (95.1%)
11. How do you consider communication about influenza vaccination from your hospital or institution? 
Excellent  19 (13.2%)
Good 62 (43.0%)
Not sufficient 63 (43.8%)
12. Do you recommend influenza vaccination to all your patients at the right time?
Yes, I recommend vaccination to all my patients without contra-indications 117 (81.2%)
No, I recommend influenza vaccination only to high risk patients 27 (18.8%)
13. What is the main reason for you to have influenza vaccination?
NB. Only 104 respondents (72.2%)
Protect oneself 63% 63 (60.6%)
Protect my patients 31% 32 (30.8%)
Protect household members 6% 6 (5.8%)
Others 3 (2.8%)
14. What is the main reason for you to refuse to have influenza vaccination?
NB. Only 31 respondents (21.5%)
Lack of time 14 (45.2%)
Concerns about side effects 7 (22.6%)
No fear of influenza infection 7 (22.6%)
Disagreement with indication of vaccination for health-care workers 3 (9.6%)
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Results
Among the 1,776 IRS members who have been invited 
to participate to the study, 144 (8.1%) completed the sur-
vey (97 men; median age 59 years, IQR 47 - 66). A total 
of 19 out of 20 Italian regions were covered. Among the 
respondents, 123 were respiratory diseases, 12 internal 
medicine and 9 infectious diseases specialists. Thirty 
respondents (20.8%) were employed at academic in-
stitutions. The majority of the respondents reported to 
recommend influenza vaccination to all their patients 
who do not have contra-indications (81%), while the re-
maining (19%) reported to advice on vaccination only 
high-risk patients. More than two thirds of respondents 
considered influenza vaccination safe even for immuno-
compromised/immunosuppressed patients. A total of 29 
(20%) participants affirmed that vaccination can cause 
influenza. Co-administration of pneumococcal and in-
fluenza vaccine was considered a reasonable strategy for 
almost all respondents (99%) and 49% of respondents 
were aware of quadrivalente vaccine availability in Italy. 
More than 50% of respondents underwent seasonal in-
fluenza vaccination in 2015 and 68% declared the inten-
tion to undergo vaccination in current epidemic season. 
Reasons for having vaccination were reported by 72% of 
the vaccinated respondents and mainly refer to ‘protect 
oneself from influenza’ (63%), ‘protect patients’ (31%) 
and ‘protect household members’ (6%). The main rea-
sons for vaccination refusal were ‘lack of time’ (45%), 
‘concerns about side effects’ (22%), ‘do not get influen-
za easily and/or not afraid of influenza infection’ (22%) 
and ‘disagreement with indication of vaccination for 
HCWs’ (9%). 
Discussion
The present survey shows a general good understand-
ing of the indications for influenza vaccination among 
Italian physicians taking care patients with respiratory 
diseases. However, a subgroup of respondents showed 
inadequate understanding on important issues, as vac-
cination safety. Lack of knowledge and concerns about 
safety may affect vaccination rate. Despite these limita-
tions, vaccination rate in this population is higher than 
previously reported. 
The response rate of this survey was lower than expected 
and, despite the target population was mainly made of 
specialists dealing with respiratory infections, our as-
sumption is that the issue being addressed might not be 
of interest for most of the invitees. This scenario is even 
more alarming in consideration of the large amount of ef-
forts spent by health authorities to change the attitude of 
HCWs and the public toward influenza vaccination [7].
The survey highlights that influenza vaccination is a 
common recommendation, at least for high risk groups 
of patients. The relatively high rate of respondents af-
firming that vaccination can cause influenza reveals 
that unreasonable concerns about side effects are com-
mon even among specialists. No difference between 
this group and other respondents was observed in term 
of age, working place and vaccination rate. A further 
statistical description was not possible due to the small 
sample size. Inadequate knowledge among HCWs on 
such an important issue as vaccine safety may result in 
false information to patients, thus possibly affecting the 
success of vaccination campaigns [8]. These results em-
phasize the strong need to target HCWs with an appro-
priate training which has been missed in Italy over the 
past decades. Specific information and proper tailored 
educational programs need to be improved by health 
authorities and institution in consideration that almost 
44% of participants rated communication strategies 
about influenza vaccination as rather unsatisfactory. The 
2016 statement for the prevention of influenza edited by 
the Italian public health authority strongly recommends 
influenza vaccination among HCWs as a cost-effective 
measure to reduce infection among medical personnel 
and prevent morbidity and mortality among high risk 
group of patients [9]. Despite these recommendations, 
vaccination coverage rates seem to be very low in Italy 
and across Europe [10]. A cross-sectional survey carried 
during two 2007/2008 influenza seasons in several Euro-
pean countries confirmed that the coverage rates among 
HCWs were generally low, ranging from the lowest rate 
of 6.4% in Poland to 26.3% in Czech Republic; in Italy, 
the vaccination coverage rate among HCWs was about 
12% [10]. Differently, in this survey more than the half of 
participants had seasonal influenza vaccination in 2016 
resulting in a coverage level far better than previously 
reported. Consistently with this report, the majority of 
respondents declared the intention to undergo vaccina-
tion in that season and up to 90% would recommend it 
to colleagues. Vaccination coverage rate presented here 
is still suboptimal but higher than the rate reported by 
previous experiences [10, 11]. As already noted by Blasi 
and colleagues in a similar experience, this may be due 
to the high prevalence of pulmonologists in this popula-
tion [12]. Specialists dealing with respiratory infections 
may be more sensitized towards influenza vaccination 
than other colleagues. 
The generalizability of the study should be carefully 
considered under the light of several limitations. First, 
as discussed above, the response rate is lower than ex-
pected affecting the reproducibility of the results on a 
larger scale. Secondly, self-reporting may affect the 
quality of data presented here. Thirdly, the proportion of 
the vaccinated physicians among the non-respondents is 
impossible to be assessed. Fourthly, physicians choosing 
to answer the questionnaire may have been more moti-
vated towards vaccination, so that a selection bias cannot 
be ruled out. Finally, the collection of data might miss 
a part of the vaccination season due to the point-prev-
alence design of the study. On the other hand, this sur-
vey provides a real-life snapshot on the lack of interest 
among HCWs toward seasonal influenza vaccination. In 
addition, our analysis has suggested a subgroup among 
specialists with inadequate knowledge about vaccination 
safety. A further characterization should be needed in or-
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der to provide this population with targeted educational 
interventions.
Conclusions
The promotion of better knowledge and proper attitude 
for Italian specialists towards influenza vaccination re-
mains an unmet goal and should be addressed by a mul-
tifaceted intervention, including appropriate training and 
the promotion of proactive attitudes.
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